# Vaccine Against Atherosclerosis in Patients With Overweight Problems or Obesity

Study · id `cardio:ct-nct03042741` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03042741](<https://clinicaltrials.gov/study/NCT03042741>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT03042741

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 300 participants.

## Technical summary

Registry record NCT03042741. Randomized; triple masking; primary purpose treatment. Start 2017-02-01 (actual); primary completion 2019-12-18 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; triple masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 300 participants (planned count; ClinicalTrials.gov record NCT03042741, source copy `cardio:ctgov-nct03042741-2019-04-16`, retrieved 2026-10-31)
- Started: 2017-02-01 (actual) (ClinicalTrials.gov record NCT03042741, source copy `cardio:ctgov-nct03042741-2019-04-16`, retrieved 2026-10-31)
- Primary completion: 2019-12-18 (anticipated) (ClinicalTrials.gov record NCT03042741, source copy `cardio:ctgov-nct03042741-2019-04-16`, retrieved 2026-10-31)
- Completion: 2019-12-18 (anticipated) (ClinicalTrials.gov record NCT03042741, source copy `cardio:ctgov-nct03042741-2019-04-16`, retrieved 2026-10-31)
- Countries: Mongolia (ClinicalTrials.gov record NCT03042741, source copy `cardio:ctgov-nct03042741-2019-04-16`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03042741-2019-04-16`, retrieved 2026-10-31)

## The registry's words

- Brief title: Vaccine Against Atherosclerosis in Patients With Overweight Problems or Obesity
- Acronym: V6
- Condition: Atherosclerosis
- Intervention (Biological): atherosclerosis vaccine
- Intervention (Biological): Placebo pills
- Lead sponsor: Immunitor LLC
- Lead sponsor class: INDUSTRY
- Collaborator: Federal State Budget Institution Research Center for Obstetrics, Gynecology and Perinatology Ministry of Healthcare
- Collaborator class: OTHER\_GOV

## Connected pages

- Registry condition terms include this condition: Atherosclerosis (`cardio:atherosclerosis`)

## Provenance

Content hash: c4e3a016037edde7b73d5e3d2d2389e08484f64533c1cfbaa3d4bc2a6de07cca
Last substantive edit: 2026-10-31
Evidence last checked: Not recorded
